A preliminary investigation of the pharmacokinetics and pharmacodynamics of amikacin/fosfomycin combination against Acinetobacter baumannii using a dynamic in vitro hollow-fibre infection model (2015–2016)

Grant type:
Cardeas Pharma Corporation
Researchers:
Funded by:
Cardeas Pharma Corporation